You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Kidney (Renal Cell) Cancer, Melanoma, Prostate Cancer,

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul

Recruiting
  • Urological Malignancies
  • +4 more
    • Seoul, Korea, Republic of
      Yonsei Severance Hospital
    Jan 30, 2023

    Stereotactic Body Radiotherapy for Medically Inoperable

    Recruiting
    • Kidney Neoplasm
    • +2 more
    • SBRT
    • Terrassa, Barcelona, Spain
      Consorci Sanitari de Terrassa
    Apr 5, 2023

    Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

    Active, not recruiting
    • Bladder Urothelial Carcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 2, 2022

    Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

    Completed
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2022

    Prostate, Lung, Melanoma and Breast Cancer Patients Following

    Recruiting
    • Prostate Cancer
    • +3 more
    • SBRT
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Spontaneous Regression in Metastatic Melanoma and Renal Cell

    Active, not recruiting
    • Melanoma; Renal Cell Carcinoma
    • Blood collection for laboratory studies
    • Data collection from medical record
    • Indianapolis, Indiana
      Indiana University Simon Cancer Center
    Apr 1, 2022

    Kidney Cancer Trial in Houston (Axitinib)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 2, 2022

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

    Not yet recruiting
    • Metastatic Clear Cell Renal Cell Carcinoma
    • With Positive PSMA Expression at Tumor Sites
    • 177Lu-PSMA-1 (radiopharmaceutical)
    • (no location specified)
    Sep 26, 2023

    Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +9 more
    • Biospecimen Collection
    • Electronic Health Record Review
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 4, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Not yet recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +12 more
    • Biopsy
    • +8 more
    • (no location specified)
    Jun 8, 2023

    Nivolumab in Recurring Kidney Cancer Participants

    Completed
    • Kidney Cancer
    • Renal Cancer
    • Non-Interventional
    • Tokyo, Japan
      Local Institution - 0001
    Oct 19, 2022

    Kidney Tumor Trial in France (blood sampling for ITK dosage)

    Recruiting
    • Kidney Neoplasm
    • blood sampling for ITK dosage
    • Marseille, France
    • +4 more
    Jan 6, 2023

    Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

    Active, not recruiting
    Has Results
    • Renal Cancer
    • Dendritic Cell Tumor Fusion Vaccine
    • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Jan 2, 2023

    Appropriate Dosing to Optimise Personalised Cancer Treatments

    Completed
    • Melanoma Stage III
    • +5 more
    • Dried blood Spot (DBS)
    • Venous blood sampling
    • Dundee, Scotland, United Kingdom
      NHS Tayside and University of Dundee
    Feb 25, 2022

    Immunophenotyping in Metastatic Kidney Cancer Patients Receiving

    Recruiting
    • Metastatic Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2023

    Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

    Recruiting
    • Kidney Cancer
    • cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 2, 2022

    Benign Kidney Tumor, Kidney Tumor, Renal Cell Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic

    Recruiting
    • Benign Kidney Neoplasm
    • +2 more
    • Hyperpolarized Carbon C 13 Pyruvate
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

    Completed
    Has Results
    • Renal Cell Carcinoma
    • +3 more
    • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors

    Not yet recruiting
    • Childhood Cancer
    • +4 more
      • (no location specified)
      Nov 28, 2023

      Biomarkers of Renal Cancer

      Recruiting
      • Renal Cell Carcinoma
      • +3 more
        • Firenze, Italy
        • +3 more
        Mar 14, 2023

        Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

        Not yet recruiting
        • Carcinoma, Renal Cell
        • Pittsburgh, Pennsylvania
          UPMC Department of Urology
        Jan 5, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

        Active, not recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +20 more
        • Ipilimumab
        • +3 more
        • Tampa, Florida
        • +6 more
        Jan 13, 2023